Sermorelin Protocol: Complete Cycling & Dosing Guide

Overview

Sermorelin acetate is a synthetic peptide that mimics the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). Unlike exogenous recombinant human growth hormone, sermorelin works through the hypothalamic-pituitary axis, stimulating your body's own pituitary gland to produce and release growth hormone naturally. This preserves physiological feedback mechanisms and carries a lower risk of GH excess compared to direct GH administration.

Sermorelin's primary mechanism involves binding to GHRH receptors on somatotroph cells in the anterior pituitary, triggering pulsatile GH release. The released GH then stimulates hepatic production of IGF-1, which mediates downstream anabolic, lipolytic, and tissue-repair effects. This makes sermorelin popular for clinical growth hormone deficiency, age-related GH decline, body composition optimization, and off-label anti-aging protocols.

Practical Classification:

• Type: Peptide (GHRH analog)
• Route: Subcutaneous injection
• Dosing Range: 200–500 mcg once daily
• Typical Monthly Cost: $80–$300
• Prescription Status: Requires medical supervision in the United States and most countries

Standard Protocol

Baseline Dosing Strategy

Most users begin at the lower end of the dosing spectrum and titrate upward based on tolerance and response. The standard entry protocol looks like this:

Week 1–2: Loading Phase (200 mcg daily)

• Inject 200 mcg subcutaneously once daily, preferably in the evening or before bed
• This establishes baseline tolerance and allows you to assess for side effects
• Keep injection sites rotated (abdomen, thigh, upper arm) to minimize localized reactions

Week 3–4: Standard Dose (300 mcg daily)

• Increase to 300 mcg daily once you've confirmed tolerance
• This is the most commonly effective dose range for measurable IGF-1 elevation and GH response
• Continue rotating injection sites

Week 5+: Optimization Phase (300–500 mcg daily)

• Most users find 300–400 mcg daily optimal for balancing efficacy and side effects
• Some advanced users escalate to 500 mcg, but this carries increased risk of water retention, headache, and facial flushing
• Only increase if response is suboptimal and side effects remain minimal

Cycle Structure

Sermorelin is not typically run in strict "on/off" cycles like anabolic steroids, because it doesn't suppress the hypothalamic-pituitary-gonadal (HPG) axis. However, to preserve receptor sensitivity and prevent tachyphylaxis (diminished response over time), most protocols implement a structured approach:

Continuous Protocol (Most Common):

• Daily dosing for 12–16 weeks continuously
• One to two-week break every 12–16 weeks
• Reassess IGF-1 levels and GH response after the break
• Resume at the same dose or adjust based on blood work

Pulsatile Protocol (Advanced):

• Inject sermorelin 5 days on, 2 days off (e.g., Monday–Friday dosing, weekend off)
• Mimics natural GH pulsatility more closely
• May reduce tachyphylaxis compared to continuous daily dosing
• Requires more discipline but some report better long-term response

Cycling Protocol (Conservative):

• 12 weeks on, 4 weeks off
• Allows for full receptor reset and natural GH recovery
• Repeatable indefinitely without habituation
• Best for users concerned about long-term tolerance

Goal-Specific Protocols

Fat Loss Protocol

Objective: Leverage GH/IGF-1 elevation for lipolytic effects and metabolic optimization.

Duration: 12–16 weeks continuously

Dosing:

• Weeks 1–2: 200 mcg daily
• Weeks 3–16: 300–400 mcg daily

Timing: Inject in the evening or before bed. GH is secreted naturally during sleep, and injecting sermorelin before sleep may enhance the natural pulsatile response.

Nutrition Protocol:

• Maintain a moderate caloric deficit (300–500 calories below maintenance)
• Prioritize protein (1 gram per pound of body weight)
• Sermorelin works synergistically with caloric deficit; expect modest enhancements, not dramatic fat loss alone

Monitoring:

• Measure IGF-1 at weeks 4, 8, and 12
• Expected IGF-1 elevation: 50–100 ng/mL above baseline (similar to clinical data)
• Adjust dose upward if IGF-1 remains low or flat

Muscle Gain & Lean Mass Protocol

Objective: Stimulate GH and IGF-1 for anabolic effects and tissue repair.

Duration: 12–20 weeks

Dosing:

• Weeks 1–2: 200 mcg daily
• Weeks 3–20: 350–500 mcg daily (higher dose range to maximize IGF-1 stimulus)

Stacking Recommendation: Sermorelin responds well to concurrent testosterone replacement or testosterone therapy (TRT). The combination of elevated IGF-1 and testosterone creates a synergistic anabolic environment.

Training Protocol:

• Progressive resistance training 4–5 days per week
• Focus on compound movements with progressive overload
• GH/IGF-1 elevation supports recovery and collagen synthesis

Nutrition:

• Caloric surplus: +300–500 calories above maintenance
• Protein: 1.2–1.5 grams per pound of body weight
• Carbohydrates strategically timed around training

Monitoring:

• IGF-1 labs at weeks 4, 8, 12, and 16
• Track body weight, waist circumference, and strength metrics weekly
• Expect 2–5 pounds of lean mass gain over 12 weeks (conservative estimate based on available evidence)

Anti-Aging & Recovery Protocol

Objective: Stimulate GH for systemic repair, immune function, and recovery from training or injury.

Duration: 12–16 weeks, then reassess

Dosing:

• Weeks 1–4: 200–250 mcg daily
• Weeks 5–16: 250–350 mcg daily (lower-to-moderate range, emphasizing tolerability over aggression)

Frequency: Daily injection without interruption during the on-phase

Lifestyle Integration:

• Sleep 7–9 hours nightly (GH secretion is sleep-dependent)
• Stress management and recovery emphasis over intense training
• Mobility work and soft-tissue care

Monitoring:

• IGF-1 baseline and at week 8
• Fasting glucose at weeks 4 and 12 (to monitor for glucose dysregulation)
• Thyroid function panel (TSH, free T3, free T4) every 8 weeks

Injury Recovery Acceleration Protocol

Objective: Support tissue repair and recovery from acute or chronic injury.

Duration: 8–12 weeks or until clinical recovery

Dosing:

• Weeks 1–2: 200 mcg daily
• Weeks 3–12: 300–400 mcg daily

Timing: Consistent daily injection. Some evidence suggests evening dosing may favor tissue repair during sleep recovery.

Rehabilitation Integration:

• Physical therapy 4–5 days per week (active recovery, graduated loading)
• Adequate protein intake (1.2–1.5 grams per pound of body weight)
• Anti-inflammatory management (diet, ice/heat as appropriate, NSAIDs if indicated)

Monitoring:

• Clinical assessments of pain, range of motion, and functional capacity every 2 weeks
• IGF-1 lab at weeks 4 and 8
• Discontinue if no progress after 6–8 weeks and reassess with healthcare provider

How to Administer Step-by-Step

Reconstitution (First-Time Setup)

1. Gather supplies: Sterile syringe (1 mL), 29–31 gauge needle, alcohol swab, bacteriostatic water (usually provided with kit)
2. Inspect vial: Sermorelin powder should be white/off-white. Discard if discolored or compromised.
3. Swab the rubber top of both the sermorelin vial and bacteriostatic water vial with an alcohol swab. Let dry 30 seconds.
4. Draw bacteriostatic water into the syringe (volume depends on desired concentration; commonly 2–3 mL for a 5 mg vial)
5. Inject water slowly into the sermorelin vial, aiming the stream against the vial wall (not directly onto the powder) to prevent foaming
6. Let it sit 2–3 minutes without agitation. Gently swirl (do not shake vigorously) until powder fully dissolves
7. Verify clarity: The solution should be clear and colorless. If cloudy, discard and restart
8. Label the vial with date of reconstitution and expiration (typically 30 days refrigerated)

Daily Injection Protocol

1. Prepare the injection site: Clean skin with an alcohol swab (abdomen, outer thigh, or upper arm). Let dry completely.
2. Load the syringe: Draw the appropriate dose (e.g., 300 mcg) from the reconstituted vial using a fresh, sterile syringe and needle
3. Pinch the skin: Gently pinch a fold of skin at the injection site to elevate the subcutaneous tissue
4. Insert at 45–90 degrees: Insert the needle swiftly at a 45–90-degree angle into the pinched skin
5. Inject slowly: Push the plunger steadily to deliver the full dose over 5–10 seconds
6. Withdraw and apply pressure: Remove the needle and apply gentle pressure with a clean tissue for 10–15 seconds
7. Rotate sites: Use different injection sites daily to prevent lipohypertrophy (fatty lumps) and localized irritation
8. Dispose safely: Place used syringes/needles in a sharps container (never regular trash)

Storage Requirements

• Sealed vial (powder): Room temperature, protected from light, for 18–24 months
• Reconstituted vial: Refrigerated (2–8°C), away from light, for 30 days
• Pre-loaded syringes (if prepared): Refrigerated, for up to 7 days if kept sterile
• Never freeze reconstituted sermorelin; freezing destroys peptide integrity
• Keep away from direct sunlight and excessive heat at all times

Cycle Example: Week-by-Week Schedule

12-Week Fat Loss Cycle

What to Expect: Timeline of Effects

Week 1–2 (Adjustment Phase)

• Possible facial flushing shortly after injection (typically mild and transient)
• Mild headache in 20–30% of users; usually resolves within hours
• Injection site redness or minor swelling (normal; resolves within hours)
• No measurable GH or IGF-1 changes yet

Week 3–4 (Early Response)

• GH pulsatility should increase measurably (confirmed via 24-hour GH secretion tests if monitored)
• Mild water retention possible (1–3 pounds)
• Sleep quality may improve slightly in some users
• Facial flushing may recur but is typically dose-dependent and temporary

Week 5–8 (Measurable IGF-1 Elevation)

• IGF-1 levels rise noticeably (expect 50–100 ng/mL increase from baseline)
• Improved recovery from training; reduced delayed-onset muscle soreness (DOMS)
• Enhanced energy or sense of well-being (subjective; not universal)
• Possible mild dizziness if doses exceed 400 mcg; reduce dose if this occurs

Week 9–12 (Adaptation & Optimization)

• IGF-1 plateau at new, elevated steady state
• Most body composition changes (if any) emerge during this window
• Skin texture and hydration may improve subtly
• Training recovery remains enhanced

Week 12+ (Long-Term Response)

• Continued IGF-1 elevation; no further rise expected without dose increase
• Tachyphylaxis risk increases after 16 weeks of continuous dosing
• If taking a break, GH and IGF-1 return toward baseline within 7–10 days

Common Protocol Mistakes

Mistake 1: Overdosing Too Early

The Problem: Starting at 400–500 mcg to "maximize gains" leads to excessive side effects (flushing, headache, water retention) and poor adherence.

The Fix: Start at 200 mcg and titrate slowly. Higher dose ≠ better results; the dose-response curve plateaus, and side effects escalate disproportionately at higher doses.

Mistake 2: Ignoring IGF-1 Monitoring

The Problem: Injecting blindly without blood work means you can't assess whether the compound is actually working or whether your dose is appropriate.

The Fix: Measure baseline IGF-1, repeat at weeks 4–8, and adjust dose based on results. A 50–100 ng/mL increase is a good sign; if IGF-1 remains flat, increase dose or investigate other factors (poor injection technique, suboptimal storage, absorption issues).

Mistake 3: Inconsistent Injection Timing

The Problem: Injecting at random times (sometimes morning, sometimes evening) disrupts GH pulsatility and makes it harder to assess true response.

The Fix: Establish a consistent injection time (preferably evening/before bed) and stick to it daily. Consistency improves GH response prediction and makes troubleshooting easier.

Mistake 4: Improper Reconstitution

The Problem: Shaking the vial vigorously, using non-sterile water, or adding too much water reduces peptide stability and potency.

The Fix: Swirl gently (never shake), use bacteriostatic water provided, and reconstitute at a concentration that works for your dosing volume (usually 100–200 mcg/mL).

Mistake 5: Running Continuously Without Breaks

The Problem: Injecting daily for 24+ weeks without cessation can lead to pituitary receptor downregulation and tachyphylaxis, making the compound progressively less effective.

The Fix: Implement a structured cycle (e.g., 12–16 weeks on, 1–2 weeks off) or rotate between continuous and pulsatile protocols to maintain sensitivity.

Mistake 6: Poor Injection Site Rotation

The Problem: Injecting the same spot repeatedly causes lipohypertrophy (fatty knots), poor absorption, and localized inflammation.

The Fix: Rotate between abdomen (left, right, upper, lower quadrants), thighs, and upper arms. Use a new injection site each day; return to the same spot only after 5–7 days.

How to Stack with Other Compounds

Sermorelin + Testosterone Replacement Therapy (TRT)

Rationale: Testosterone and IGF-1 work synergistically on muscle protein synthesis and anabolic signaling.

Practical Protocol:

• Run sermorelin 300–400 mcg daily
• Maintain stable TRT dose (typically 100–200 mg testosterone per week, depending on body weight and goals)
• IGF-1 elevation may enhance testosterone's anabolic effects and improve recovery
• Monitor estradiol (testosterone aromatization may increase with elevated IGF-1); manage with AI if needed

Monitoring: IGF-1, testosterone, free testosterone, estradiol every 8 weeks